Citation
85 FR 4332
Multiple canonical documents share this first-page citation.
- Prospective Grant of Exclusive Patent License: Antibody-Based Therapeutics and Chimeric Antigen Receptors Targeting Glypican-2 Friday, January 24, 2020 85 FR 4332
- Submission for OMB Review; 30-Day Comment Request; Information Program on Clinical Trials: Maintaining a Registry and Results Databank (National Library of Medicine) Friday, January 24, 2020 85 FR 4332